M Margeli
Overview
Explore the profile of M Margeli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Aparicio J, Maroto P, Garcia Del Muro X, Sanchez-Munoz A, Guma J, Margeli M, et al.
Ann Oncol
. 2014 Sep;
25(11):2173-2178.
PMID: 25210015
Background: We aimed to analyze prognostic factors for relapse in stage I seminoma managed by either active surveillance or adjuvant chemotherapy, and to describe the long-term patterns of recurrence in...
12.
Font R, Espinas J, Gil-Gil M, Barnadas A, Ojeda B, Tusquets I, et al.
Br J Cancer
. 2012 Sep;
107(8):1249-56.
PMID: 22955858
Aims: To compare different methods in order to assess adherence and persistence with oral endocrine therapy in women diagnosed with breast cancer (BC) in Catalonia. Materials And Methods: This study...
13.
Martin M, Sanchez-Rovira P, Munoz M, Baena-Canada J, Mel J, Margeli M, et al.
Ann Oncol
. 2011 Mar;
22(12):2591-2596.
PMID: 21421542
Background: In order to determine the feasibility of substituting pegylated liposomal doxorubicin (PLD) for doxorubicin in combination with cyclophosphamide and trastuzumab as adjuvant therapy, we conducted a phase II study...
14.
Font A, Arellano A, Fernandez-Llamazares J, Casas D, Boix J, Cardenal J, et al.
Clin Transl Oncol
. 2007 Apr;
9(3):177-82.
PMID: 17403629
Introduction: To evaluate the efficacy and tolerability of weekly docetaxel concurrent with radiotherapy in inoperable oesophageal cancer patients. Material And Methods: Thirty-four oesophageal cancer patients with co-morbid medical conditions, locally...
15.
Font A, Sanchez J, Rosell R, Taron M, Martinez E, Guillot M, et al.
Lung Cancer
. 2002 Jul;
37(2):213-8.
PMID: 12140145
Based on the synergistic cytotoxicity demonstrated in vitro by topoisomerase I inhibitors followed by docetaxel and the feasibility of giving both drugs on a weekly schedule avoiding overlapping toxicities, we...